Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease
出版年份 2014 全文链接
标题
Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease
作者
关键词
Tiotropium, Chronic Obstructive Pulmonary Disease Exacerbation, Major Adverse Cardiovascular Event, Tiotropium Bromide, Tiotropium HandiHaler
出版物
DRUGS
Volume 74, Issue 15, Pages 1801-1816
出版商
Springer Nature
发表日期
2014-10-09
DOI
10.1007/s40265-014-0307-4
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Suppressive activity of tiotropium bromide on matrix metalloproteinase production from lung fibroblasts in vitro
- (2016) Kazuhito Asano International Journal of Chronic Obstructive Pulmonary Disease
- Comparative mortality risk of tiotropium administered via handihaler or respimat in COPD patients: Are they equivalent?
- (2014) Alexander G. Mathioudakis et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm?
- (2014) Neil C Barnes et al. THORAX
- Inhaler Devices for Patients with COPD
- (2013) James B. Fink et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Use of tiotropium Respimat Soft Mist InhalerversusHandiHaler and mortality in patients with COPD
- (2013) Katia M.C. Verhamme et al. EUROPEAN RESPIRATORY JOURNAL
- Tiotropium Respimat increases the risk of mortality: pro
- (2013) Richard Beasley EUROPEAN RESPIRATORY JOURNAL
- Tiotropium Respimat increases the risk of mortality: con
- (2013) Eric D. Bateman EUROPEAN RESPIRATORY JOURNAL
- Pharmacokinetics and pharmacodynamics of tiotropium solution and tiotropium powder in chronic obstructive pulmonary disease
- (2013) J.M. Hohlfeld et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor
- (2013) Christofer S. Tautermann et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tiotropium Respimat Inhaler and the Risk of Death in COPD
- (2013) Robert A. Wise et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thoraxeditorial by Jenkins and Beasley related to tiotropium respimat
- (2013) Norbert Metzdorf et al. THORAX
- Ten years of tiotropium: clinical impact and patient perspectives
- (2013) Abebaw Yohannes et al. International Journal of Chronic Obstructive Pulmonary Disease
- Tiotropium Bromide Inhalation Powder
- (2012) Gillian M. Keating DRUGS
- Effect of Switching Tiotropium HandiHaler® to Respimat® Soft Mist™ Inhaler in Patients with COPD: The Difference of Adverse Events and Usability Between Inhaler Devices
- (2012) Yuka Asakura et al. Journal of Aerosol Medicine and Pulmonary Drug Delivery
- Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials
- (2012) Yaa-Hui Dong et al. THORAX
- Tiotropium HandiHaler® in the treatment of COPD: A safety review
- (2012) Steven Kesten International Journal of Chronic Obstructive Pulmonary Disease
- Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD
- (2011) Rick Hodder et al. International Journal of Chronic Obstructive Pulmonary Disease
- Organic Cation Transporter-Mediated Renal Secretion of Ipratropium and Tiotropium in Rats and Humans
- (2010) T. Nakanishi et al. DRUG METABOLISM AND DISPOSITION
- A one-year trial of tiotropium Respimat® plus usual therapy in COPD patients
- (2010) E.D. Bateman et al. RESPIRATORY MEDICINE
- Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease
- (2010) Heike Rau-Berger et al. International Journal of Chronic Obstructive Pulmonary Disease
- Tiotropium bromide inhibits TGF-ß-induced MMP production from lung fibroblasts by interfering with Smad and MAPK pathways in vitro
- (2010) Kazuhito Asano International Journal of Chronic Obstructive Pulmonary Disease
- Cardiovascular Safety of Tiotropium in Patients With COPD
- (2009) Bartolome Celli et al. CHEST
- Tiotropium and risk for fatal and nonfatal cardiovascular events in patients with chronic obstructive pulmonary disease: Systematic review with meta-analysis
- (2009) Gustavo J. Rodrigo et al. RESPIRATORY MEDICINE
- Tiotropium 5μg via Respimat and 18μg via HandiHaler; efficacy and safety in Japanese COPD patients
- (2009) M. Ichinose et al. RESPIRATORY MEDICINE
- Inhaled Anticholinergics and Risk of Major Adverse Cardiovascular Events in Patients With Chronic Obstructive Pulmonary Disease
- (2008) Sonal Singh JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
- (2008) Donald P. Tashkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy of tiotropium administered via Respimat® Soft Mist™ Inhaler or HandiHaler® in COPD patients
- (2008) J.A. van Noord et al. RESPIRATORY MEDICINE
- A randomized study of tiotropium Respimat® Soft MistTM Inhaler vs. ipratropium pMDI in COPD
- (2007) T. Voshaar et al. RESPIRATORY MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More